A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study

EuroIntervention. 2024 Sep 2;20(17):e1118-e1120. doi: 10.4244/EIJ-D-24-00355.

Authors

Michael Haude¹, Juan F Iglesias², Hector M Garcia-Garcia³, Dimitrios Barlagiannis¹, Sophie Degrauwe², Gebremedhin Melaku³, Solomon Beyene³, Ron Waksman³

Affiliations

¹ Medical Clinic I, Rheinland Klinikum Neuss GmbH, Lukaskrankenhaus, Neuss, Germany.
² Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
³ Interventional Cardiology, MedStar Washington Hospital Center, Washington, D.C., USA.

PMID: 39219359
PMCID: PMC11352512 (available on 2025-09-02)
DOI: 10.4244/EIJ-D-24-00355

No abstract available

MeSH terms

Absorbable Implants*
Coronary Artery Disease / surgery
Coronary Artery Disease / therapy
Drug-Eluting Stents
Female
Humans
Magnesium*
Male
Middle Aged
Percutaneous Coronary Intervention / instrumentation
Percutaneous Coronary Intervention / methods
Prosthesis Design
Tissue Scaffolds
Treatment Outcome

Substances

Magnesium